These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1208 related items for PubMed ID: 29277949

  • 1. Development and clinical validation of a circulating tumor DNA test for the identification of clinically actionable mutations in nonsmall cell lung cancer.
    Liu L, Liu H, Shao D, Liu Z, Wang J, Deng Q, Tang H, Yang H, Zhang Y, Qiu Y, Cui F, Tan M, Zhang P, Li Z, Liu J, Liang W, Wang Y, Peng Z, Wang J, Yang H, Mao M, Kristiansen K, Ye M, He J.
    Genes Chromosomes Cancer; 2018 Apr; 57(4):211-220. PubMed ID: 29277949
    [Abstract] [Full Text] [Related]

  • 2. Heterogeneous mutation pattern in tumor tissue and circulating tumor DNA warrants parallel NGS panel testing.
    Guo Q, Wang J, Xiao J, Wang L, Hu X, Yu W, Song G, Lou J, Chen J.
    Mol Cancer; 2018 Aug 28; 17(1):131. PubMed ID: 30153823
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Circulating tumor DNA detection is correlated to histologic types in patients with early-stage non-small-cell lung cancer.
    Zhang B, Niu X, Zhang Q, Wang C, Liu B, Yue D, Li C, Giaccone G, Li S, Gao L, Zhang H, Wang J, Yang H, Wu R, Ni P, Wang C, Ye M, Liu W.
    Lung Cancer; 2019 Aug 28; 134():108-116. PubMed ID: 31319968
    [Abstract] [Full Text] [Related]

  • 10. Ultra-deep next-generation sequencing of plasma cell-free DNA in patients with advanced lung cancers: results from the Actionable Genome Consortium.
    Li BT, Janku F, Jung B, Hou C, Madwani K, Alden R, Razavi P, Reis-Filho JS, Shen R, Isbell JM, Blocker AW, Eattock N, Gnerre S, Satya RV, Xu H, Zhao C, Hall MP, Hu Y, Sehnert AJ, Brown D, Ladanyi M, Rudin CM, Hunkapiller N, Feeney N, Mills GB, Paweletz CP, Janne PA, Solit DB, Riely GJ, Aravanis A, Oxnard GR.
    Ann Oncol; 2019 Apr 01; 30(4):597-603. PubMed ID: 30891595
    [Abstract] [Full Text] [Related]

  • 11. Next-generation sequencing for tumor mutation quantification using liquid biopsies.
    Provencio M, Pérez-Barrios C, Barquin M, Calvo V, Franco F, Sánchez E, Sánchez R, Marsden D, Cristóbal Sánchez J, Martin Acosta P, Laza-Briviesca R, Cruz-Bermúdez A, Romero A.
    Clin Chem Lab Med; 2020 Jan 28; 58(2):306-313. PubMed ID: 31469650
    [Abstract] [Full Text] [Related]

  • 12. Quantification of mutant alleles in circulating tumor DNA can predict survival in lung cancer.
    Yang X, Zhuo M, Ye X, Bai H, Wang Z, Sun Y, Zhao J, An T, Duan J, Wu M, Wang J.
    Oncotarget; 2016 Apr 12; 7(15):20810-24. PubMed ID: 26989078
    [Abstract] [Full Text] [Related]

  • 13. The relevance of tumor mutation profiling in interpretation of NGS data from cell-free DNA in non-small cell lung cancer patients.
    Ottestad AL, Wahl SGF, Grønberg BH, Skorpen F, Dai HY.
    Exp Mol Pathol; 2020 Feb 12; 112():104347. PubMed ID: 31759951
    [Abstract] [Full Text] [Related]

  • 14. [Detection of circulating tumor DNA in epidermal growth factor receptor-TKI relapsed non-small cell lung cancer patients using next-generation sequencing and an analysis of the resistant mechanisms].
    Li Y, Zhang FS, Guo L, Ying JM.
    Zhonghua Bing Li Xue Za Zhi; 2018 Dec 08; 47(12):904-909. PubMed ID: 30522169
    [Abstract] [Full Text] [Related]

  • 15. Non-invasive detection of actionable mutations in advanced non-small-cell lung cancer using targeted sequencing of circulating tumor DNA.
    Sim WC, Loh CH, Toh GL, Lim CW, Chopra A, Chang AYC, Goh LL.
    Lung Cancer; 2018 Oct 08; 124():154-159. PubMed ID: 30268455
    [Abstract] [Full Text] [Related]

  • 16. Comparison of plasma to tissue DNA mutations in surgical patients with non-small cell lung cancer.
    Chen K, Zhang J, Guan T, Yang F, Lou F, Chen W, Zhao M, Zhang J, Chen S, Wang J.
    J Thorac Cardiovasc Surg; 2017 Sep 08; 154(3):1123-1131.e2. PubMed ID: 28625771
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Circulating Tumor DNA Detection in Early-Stage Non-Small Cell Lung Cancer Patients by Targeted Sequencing.
    Chen KZ, Lou F, Yang F, Zhang JB, Ye H, Chen W, Guan T, Zhao MY, Su XX, Shi R, Jones L, Huang XF, Chen SY, Wang J.
    Sci Rep; 2016 Aug 24; 6():31985. PubMed ID: 27555497
    [Abstract] [Full Text] [Related]

  • 19. Correlation of Somatic Genomic Alterations Between Tissue Genomics and ctDNA Employing Next-Generation Sequencing: Analysis of Lung and Gastrointestinal Cancers.
    Toor OM, Ahmed Z, Bahaj W, Boda U, Cummings LS, McNally ME, Kennedy KF, Pluard TJ, Hussain A, Subramanian J, Masood A.
    Mol Cancer Ther; 2018 May 24; 17(5):1123-1132. PubMed ID: 29500272
    [Abstract] [Full Text] [Related]

  • 20. Clinical utility of plasma-based digital next-generation sequencing in patients with advance-stage lung adenocarcinomas with insufficient tumor samples for tissue genotyping.
    Zugazagoitia J, Ramos I, Trigo JM, Palka M, Gómez-Rueda A, Jantus-Lewintre E, Camps C, Isla D, Iranzo P, Ponce-Aix S, García-Campelo R, Provencio M, Franco F, Bernabé R, Juan-Vidal O, Felip E, de Castro J, Sanchez-Torres JM, Faul I, Lanman RB, Garrido P, Paz-Ares L.
    Ann Oncol; 2019 Feb 01; 30(2):290-296. PubMed ID: 30535340
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 61.